NLRP3 and rheumatoid arthritis: For this, we applied sequential treatment with TLR4 ligand (LPS) and ATP on whole blood cells from healthy controls (n = 7, Fig. 3a) and patients with active RA (n = 7, Fig. 3b) and quantified intracellular expression of NLRP3-inflammasome-related proteins.